Literature DB >> 8274180

Chronic ethanol exposure increases lipopigment accumulation in human heart.

P Jaatinen1, P Saukko, A Hervonen.   

Abstract

The amount and distribution of myocardial lipopigments ('age pigments') were studied in alcoholic and control human hearts, to test the hypothesis of ethanol-induced long-term oxidative damage in myocardium. The amount of myocardial lipopigments was measured by image analysis in six men (age 34-60 years) who had a history of chronic alcohol misuse and who died of acute ethanol intoxication, and in their age-matched, non-alcoholic controls. Lipopigmentation in the intoxication cases was 33.5 +/- 2.8% (mean +/- SEM) higher compared to the controls in the eight myocardial areas studied (P < 0.001). A linear correlation of myocardial lipopigmentation with age was noticed in both the intoxication group (R = 0.894) and the controls (R = 0.927). The amount of lipopigments varied largely from one myocardial area to another, being highest in the most strained areas (left ventricle, interventricular septum). The accumulation of lipopigments is considered a marker of oxidative stress and ageing in the myocardium. The results support the role of free radical-induced oxidative stress in the pathogenesis of ethanol-induced cardiac abnormalities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8274180

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  3 in total

Review 1.  Oxygen, oxidative stress, hypoxia, and heart failure.

Authors:  Frank J Giordano
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 2.  Nutritional and anti-inflammatory interventions in chronic heart failure.

Authors:  Kamyar Kalantar-Zadeh; Stefan D Anker; Tamara B Horwich; Gregg C Fonarow
Journal:  Am J Cardiol       Date:  2008-06-02       Impact factor: 2.778

Review 3.  Ca(2+) signaling in the myocardium by (redox) regulation of PKA/CaMKII.

Authors:  Alex S Johnston; Stephan E Lehnart; Joseph R Burgoyne
Journal:  Front Pharmacol       Date:  2015-08-10       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.